Research brief · Metabolic
Survodutide
Dual GCG/GLP-1 agonist used in hepatic and energy expenditure research.
Class
Glucagon/GLP-1 dual agonist
Half-life
~5 days
Studied in
Hepatic lipid models, energy expenditure.
What it is
Survodutide is a glucagon/GLP-1 dual agonist investigated for hepatic lipid handling and energy expenditure endpoints in metabolic research.
Mechanism studied
Balanced glucagon and GLP-1 receptor activation.
Research notes
- Glucagon co-agonism studied for lipid oxidation effects.
Before sourcing any material
- Confirm a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity).
- Check the stated peptide content per vial, not just the gross vial mass.
- Plan reconstitution volumes first so the vial size matches your protocol.
- Verify what is lawful in your jurisdiction — these are in-vitro research reagents, not medicines.